Literature DB >> 24950750

Interest of sentinel node biopsy in apparently intrathyroidal medullary thyroid cancer: a pilot study.

M Puccini1, G Manca, C Ugolini, V Candalise, A Passaretti, J Bernardini, G Boni, P Buccianti.   

Abstract

PURPOSE: Initial surgery for medullary thyroid cancer (MTC) with no evidence of lymph node involvement in neck compartments consists of total thyroidectomy and prophylactic central neck dissection. This study evaluated the reliability of a radiotracer technique for the intraoperative detection of sentinel lymph nodes (SLNs) in lateral compartments in patients with early MTC.
METHODS: Patients with limited (cT1 N0) MTC entered the study (2009-2012). A 0.1-0.3 ml suspension of macrocolloidal technetium-99-labeled human albumin was injected (under echo-guide) in the tumor 5 h before surgery. Preoperative lymphoscintigraphy confirmed the identification of SLNs in the lateral neck. The operation consisted of total thyroidectomy and central neck dissection, and a hand-held gamma-probe (Neoprobe) guide was used to remove the SLNs from the lateral neck.
RESULTS: Four patients were recruited. The tracer always indicated a SLN. Pathology reports indicated micrometastases from MTC in SLN in three patients. At a mean follow-up of 30.5 months, all patients were biochemically cured. The technique we describe to detect and remove neck SLN from MTC seemed to be very accurate. It always showed the SLNs (usually two) in the lateral compartments. Micrometastases were detected in three of four patients, allowing their correct staging.
CONCLUSIONS: The method described here for the detection of SLNs in early MTC seems effective and reliable and can be used for a more precise N staging of the patients. It could play a role, alone or combined with other techniques, in driving the extent of prophylactic neck dissection or other potential applications.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24950750     DOI: 10.1007/s40618-014-0112-7

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  33 in total

1.  Medullary thyroid microcarcinoma: a clinicopathologic retrospective study of 38 patients with no prior familial disease.

Authors:  S Guyétant; F Dupre; J C Bigorgne; B Franc; N Dutrieux-Berger; M Lecomte-Houcke; M Patey; B Caillou; G Viennet; O Guerin; J P Saint-Andre
Journal:  Hum Pathol       Date:  1999-08       Impact factor: 3.466

Review 2.  Medullary thyroid carcinoma.

Authors:  F Pacini; M G Castagna; C Cipri; M Schlumberger
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-08       Impact factor: 4.126

3.  RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC).

Authors:  C Romei; B Cosci; G Renzini; V Bottici; E Molinaro; L Agate; P Passannanti; D Viola; A Biagini; F Basolo; C Ugolini; G Materazzi; A Pinchera; P Vitti; R Elisei
Journal:  Clin Endocrinol (Oxf)       Date:  2011-02       Impact factor: 3.478

Review 4.  Sentinel lymph node dissection for thyroid malignancy.

Authors:  P I Haigh; A E Giuliano
Journal:  Recent Results Cancer Res       Date:  2000

5.  Biomarker-based risk stratification for previously untreated medullary thyroid cancer.

Authors:  Andreas Machens; Henning Dralle
Journal:  J Clin Endocrinol Metab       Date:  2010-03-25       Impact factor: 5.958

6.  Sentinel lymph node biopsy in thyroid tumors: a pilot study.

Authors:  Sandro J Stoeckli; Madeleine Pfaltz; Hans Steinert; Stephan Schmid
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-03-18       Impact factor: 2.503

Review 7.  Targeting the RET pathway in thyroid cancer.

Authors:  Samuel A Wells; Massimo Santoro
Journal:  Clin Cancer Res       Date:  2009-11-24       Impact factor: 12.531

8.  Sporadic medullary microcarcinoma of the thyroid: a retrospective analysis of eighty cases.

Authors:  N Beressi; J M Campos; J P Beressi; B Franc; P Niccoli-Sire; B Conte-Devolx; A Murat; P Caron; L Baldet; J L Kraimps; R Cohen; J C Bigorgne; O Chabre; P Lecomte; E Modigliani
Journal:  Thyroid       Date:  1998-11       Impact factor: 6.568

Review 9.  Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinoma.

Authors:  Andreas Machens; Henning Dralle
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

10.  Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients.

Authors:  M F Saad; N G Ordonez; R K Rashid; J J Guido; C S Hill; R C Hickey; N A Samaan
Journal:  Medicine (Baltimore)       Date:  1984-11       Impact factor: 1.889

View more
  1 in total

1.  Preoperative Serum Calcitonin Level and Ultrasonographic Characteristics Predict the Risk of Metastatic Medullary Thyroid Carcinoma: Functional Analysis of Calcitonin-Related Genes.

Authors:  Yi Fan; Haishan Xu; Meiyan Lv; Ning Li
Journal:  Dis Markers       Date:  2022-03-02       Impact factor: 3.434

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.